AxoGen (AXGN) Reports In-Line Q2 EPS

AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $21.26 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS